{
    "2020-08-06": [
        [
            {
                "time": "",
                "original_text": "疫苗股集体暴跌背后：多股一个月内股价翻倍，半年报业绩平平",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "暴跌",
                        "股价翻倍",
                        "半年报",
                        "业绩平平"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【超级大单】中一签狂赚44万的大牛股跌停，百亿资金出逃医药股",
                "features": {
                    "keywords": [
                        "超级大单",
                        "大牛股",
                        "跌停",
                        "资金出逃",
                        "医药股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华讯投资：科技股为什么没有高潮",
                "features": {
                    "keywords": [
                        "华讯投资",
                        "科技股",
                        "高潮"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块持续杀跌 跌出机会了吗？李闻捷: 获利兑现施压 后期将良莠分化",
                "features": {
                    "keywords": [
                        "疫苗板块",
                        "杀跌",
                        "获利兑现",
                        "良莠分化"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "创业板指跌1.6% 疫苗股单边下挫 军工大涨",
                "features": {
                    "keywords": [
                        "创业板指",
                        "疫苗股",
                        "单边下挫",
                        "军工",
                        "大涨"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "军工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "基金人士：血制品企业盈利能力或进一步提升 估值合理 当前仍是布局良机",
                "features": {
                    "keywords": [
                        "基金人士",
                        "血制品",
                        "盈利能力",
                        "估值合理",
                        "布局良机"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块持续杀跌 康华生物、西藏药业跌停 连续下跌",
                "features": {
                    "keywords": [
                        "疫苗板块",
                        "杀跌",
                        "康华生物",
                        "西藏药业",
                        "跌停"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "科创板二次上市 康希诺疫苗“商业化”待破局",
                "features": {
                    "keywords": [
                        "科创板",
                        "康希诺",
                        "疫苗",
                        "商业化",
                        "破局"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-06",
                "original_text": "8月6日券商晨会研报汇编",
                "features": {
                    "keywords": [
                        "券商晨会",
                        "研报汇编"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "血制品行业跟踪：2020年7月血制品批签发跟踪",
                "features": {
                    "keywords": [
                        "血制品",
                        "行业跟踪",
                        "批签发"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "估值合理盈利改善，机构布局血制品行业",
                "features": {
                    "keywords": [
                        "估值合理",
                        "盈利改善",
                        "机构布局",
                        "血制品"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}